149 related articles for article (PubMed ID: 19552806)
1. Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer.
Jörissen H; Bektas N; Dahl E; Hartmann A; ten Haaf A; Di Fiore S; Kiefer H; Thess A; Barth S; Klockenbring T
BMC Cancer; 2009 Jun; 9():200. PubMed ID: 19552806
[TBL] [Abstract][Full Text] [Related]
2. Integrative genomics revealed RAI3 is a cell growth-promoting gene and a novel P53 transcriptional target.
Wu Q; Ding W; Mirza A; Van Arsdale T; Wei I; Bishop WR; Basso A; McClanahan T; Luo L; Kirschmeier P; Gustafson E; Hernandez M; Liu S
J Biol Chem; 2005 Apr; 280(13):12935-43. PubMed ID: 15659406
[TBL] [Abstract][Full Text] [Related]
3. Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer.
Dahl E; En-Nia A; Wiesmann F; Krings R; Djudjaj S; Breuer E; Fuchs T; Wild PJ; Hartmann A; Dunn SE; Mertens PR
BMC Cancer; 2009 Nov; 9():410. PubMed ID: 19930682
[TBL] [Abstract][Full Text] [Related]
4. Identification of RAI3 as a therapeutic target for breast cancer.
Nagahata T; Sato T; Tomura A; Onda M; Nishikawa K; Emi M
Endocr Relat Cancer; 2005 Mar; 12(1):65-73. PubMed ID: 15788639
[TBL] [Abstract][Full Text] [Related]
5. High levels of RAI3 expression is linked to shortened survival in esophageal cancer patients.
El Gammal AT; Melling N; Reeh M; Gebauer F; Mann O; Perez D; Bockhorn M; Bachmann K; Izbicki JR; Grupp K
Exp Mol Pathol; 2019 Apr; 107():51-56. PubMed ID: 30707896
[TBL] [Abstract][Full Text] [Related]
6. Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody.
Hnatyszyn HJ; Liu M; Hilger A; Herbert L; Gomez-Fernandez CR; Jorda M; Thomas D; Rae JM; El-Ashry D; Lippman ME
Breast Cancer Res Treat; 2010 Jul; 122(2):371-80. PubMed ID: 19842031
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis.
Serce NB; Boesl A; Klaman I; von Serényi S; Noetzel E; Press MF; Dimmler A; Hartmann A; Sehouli J; Knuechel R; Beckmann MW; Fasching PA; Dahl E
BMC Cancer; 2012 Dec; 12():597. PubMed ID: 23236990
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid-induced protein 3: identification and characterisation of a novel prognostic colon cancer biomarker.
Zougman A; Hutchins GG; Cairns DA; Verghese E; Perry SL; Jayne DG; Selby PJ; Banks RE
Eur J Cancer; 2013 Jan; 49(2):531-9. PubMed ID: 23021913
[TBL] [Abstract][Full Text] [Related]
9. Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues.
Hawse JR; Carter JM; Aspros KGM; Bruinsma ES; Koepplin JW; Negron V; Subramaniam M; Ingle JN; Rech KL; Goetz MP
Breast Cancer Res Treat; 2020 Jan; 179(1):241-249. PubMed ID: 31571071
[TBL] [Abstract][Full Text] [Related]
10. Development of a monoclonal antibody that specifically detects tissue inhibitor of metalloproteinase-4 (TIMP-4) in formalin-fixed, paraffin-embedded human tissues.
Donover PS; Wojciechowski BS; Thirumaran R; Zemba-Palko V; Prendergast GC; Wallon UM
J Cell Biochem; 2010 Aug; 110(5):1255-61. PubMed ID: 20564221
[TBL] [Abstract][Full Text] [Related]
11. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
12. Native human autoantibodies targeting GIPC1 identify differential expression in malignant tumors of the breast and ovary.
Yavelsky V; Rohkin S; Shaco-Levy R; Tzikinovsky A; Amir T; Kohn H; Delgado B; Rabinovich A; Piura B; Chan G; Kalantarov G; Trakht I; Lobel L
BMC Cancer; 2008 Aug; 8():247. PubMed ID: 18721484
[TBL] [Abstract][Full Text] [Related]
13. Systematic characterisation of GABRP expression in sporadic breast cancer and normal breast tissue.
Zafrakas M; Chorovicer M; Klaman I; Kristiansen G; Wild PJ; Heindrichs U; Knüchel R; Dahl E
Int J Cancer; 2006 Mar; 118(6):1453-9. PubMed ID: 16187283
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.
Cai D; Cao J; Li Z; Zheng X; Yao Y; Li W; Yuan Z
BMC Cancer; 2009 Apr; 9():102. PubMed ID: 19338666
[TBL] [Abstract][Full Text] [Related]
15. [Monoclonal antibody against G3BP: preparation, characterization and its application in analysis of human tumors].
Ning JY; You JF; Pei F; Wang JL; Cui XL; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2005 Apr; 34(4):215-9. PubMed ID: 16091175
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes.
Cance WG; Harris JE; Iacocca MV; Roche E; Yang X; Chang J; Simkins S; Xu L
Clin Cancer Res; 2000 Jun; 6(6):2417-23. PubMed ID: 10873094
[TBL] [Abstract][Full Text] [Related]
17. Secretory component in differentiating normal epithelium, benign lesions and malignancy in the human breast as monitored by monoclonal antibodies.
Bártek J; Tlaskalová-Hogenová H; Stasková Z; Simecková J; Vojtĕsek B; Rejthar A; Kovarík J; Bartková J
Histochemistry; 1989; 91(3):235-44. PubMed ID: 2722565
[TBL] [Abstract][Full Text] [Related]
18. Production of a monoclonal antibody against the hRRM2 subunit of ribonucleotide reductase and immunohistochemistry study of human cancer tissues.
Zhou B; Phan V; Liu X; Juhasz A; Chu PG; Yen Y
Hybridoma (Larchmt); 2006 Oct; 25(5):264-70. PubMed ID: 17044781
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer.
Bektas N; Noetzel E; Veeck J; Press MF; Kristiansen G; Naami A; Hartmann A; Dimmler A; Beckmann MW; Knüchel R; Fasching PA; Dahl E
Breast Cancer Res; 2008; 10(4):R58. PubMed ID: 18627608
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody for detection of folylpolyglutamate synthetase in paraffin embedded tissues.
Quinn AE; Pinkney M; Piggott NH; Calvert H; Milton ID; Lunec J
Hybridoma (Larchmt); 2009 Dec; 28(6):415-21. PubMed ID: 20025500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
